{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:11:54Z","timestamp":1783721514934,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijom.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T02:08:22Z","timestamp":1604282902000},"page":"906-914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients"],"prefix":"10.1016","volume":"50","author":[{"given":"M.","family":"Tsubura-Okubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2301-6895","authenticated-orcid":false,"given":"Y.","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sawatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Haruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ishihama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2020.10.004_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4081\/hr.2013.e6","article-title":"Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing camelia sinensis leaf extract","volume":"5","author":"Carulli","year":"2013","journal-title":"Hematol Rep"},{"key":"10.1016\/j.ijom.2020.10.004_bib0010","first-page":"10","article-title":"A study of stomatitis during the treatment of acute myelocytic leukemia","volume":"16","author":"Yoshida","year":"2010","journal-title":"J. Jan. Oral Muco"},{"key":"10.1016\/j.ijom.2020.10.004_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","article-title":"Management of oral mucositis in patients who have cancer","volume":"52","author":"Lalla","year":"2008","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.ijom.2020.10.004_bib0020","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/ijc.23828","article-title":"Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell\u2010induced oxidative stress","volume":"123","author":"Tsuchiya","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijom.2020.10.004_bib0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijom.2020.10.004_bib0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0360-3016(92)90768-D","article-title":"Loss of local control with prolongation in radiotherapy","volume":"23","author":"Fowler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijom.2020.10.004_bib0035","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/theoncologist.2008-0024","article-title":"Radiation treatment breaks and ulcerative mucositis in head and neck cancer","volume":"13","author":"Russo","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ijom.2020.10.004_bib0040","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijom.2020.10.004_bib0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/bmt.2011.171","article-title":"The effect of oral management on the severity of oral mucositis during hematopoietic SCT","volume":"47","author":"Yamagata","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijom.2020.10.004_bib0050","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijom.2020.10.004_bib0055","first-page":"93","article-title":"Measurement of antioxidant power of mouthwashes indicated in stomatitis","volume":"8","author":"Wakui","year":"2015","journal-title":"Asian J Pharm Clin Res"},{"key":"10.1016\/j.ijom.2020.10.004_bib0060","first-page":"29","article-title":"A traditional Japanese medicine\u2014hangeshashinto (TJ-14)\u2014alleviates chemoradiation-induced mucositis and improves rates of treatment completion","volume":"23","author":"Yamashita","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijom.2020.10.004_bib0065","first-page":"7271","article-title":"Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation","volume":"34","author":"Hayashi","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijom.2020.10.004_bib0070","first-page":"675","article-title":"New medicinal treatment for severe gingivostomatitis","volume":"2","author":"Katayama","year":"1998","journal-title":"Int Mol Med"},{"key":"10.1016\/j.ijom.2020.10.004_bib0075","first-page":"13","article-title":"Treatment with zinc preparation for severe gingivostomatitis","volume":"11","author":"Katayama","year":"2000","journal-title":"PTM"},{"key":"10.1016\/j.ijom.2020.10.004_bib0080","unstructured":"Common Terminology Criteria for Adverse Events (CT-CAE) v4.0. Bethesda, MD: National Cancer Institute, National Institutes of Health. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_40 [Accessibility verified]."},{"key":"10.1016\/j.ijom.2020.10.004_bib0085","unstructured":"GVHD version 4. The Japan Society for Hematopoietic Cell Transplantation. https:\/\/www.jshct.com\/guideline\/pdf\/01_02_gvhd_ver04.pdf [Accessibility verified January 18, 2020]."},{"key":"10.1016\/j.ijom.2020.10.004_bib0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","article-title":"Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue","volume":"110","author":"Wardley","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijom.2020.10.004_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0360-3016(03)01562-1","article-title":"Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study","volume":"58","author":"Ertekin","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijom.2020.10.004_bib0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12032-016-0795-z","article-title":"Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-l-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy","volume":"33","author":"Hayashi","year":"2016","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijom.2020.10.004_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1254\/fpj.99.255","article-title":"The gastric mucosal adhesiveness of Z-103 in rats with chronic ulcer","volume":"99","author":"Seiki","year":"1992","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.ijom.2020.10.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014637","article-title":"Beneficial effect of polaprezinc on cardiac function post-myocardial infarction: a prospective and randomized clinical trial","volume":"98","author":"Yoshikawa","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijom.2020.10.004_bib0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lfs.2013.05.019","article-title":"The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide","volume":"93","author":"Choi","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.ijom.2020.10.004_bib0120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1010716804594","article-title":"Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and TNF-alpha expression in rats with aspirin-induced gastric mucosal injury","volume":"46","author":"Naito","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijom.2020.10.004_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3565(24)35107-9","article-title":"Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-kappaB activation and interleukin-8 expression in gastric epithelial cells","volume":"291","author":"Shimada","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijom.2020.10.004_bib0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jphs.09056FP","article-title":"Polaprezinc (zinc l-carnosine) is a potent inducer of anti-oxidative stress enzyme, heme oxygenase (HO)-1\u2014a new mechanism of gastric mucosal protection","volume":"110","author":"Ueda","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ijom.2020.10.004_bib0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2036.1999.00458.x","article-title":"Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro","volume":"13","author":"Hiraishi","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijom.2020.10.004_bib0140","first-page":"144","article-title":"Efficacy and safety of polaprezinc as a preventive drug for radiation-induced stomatitis","volume":"62","author":"Masayuki","year":"2002","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi"},{"key":"10.1016\/j.ijom.2020.10.004_bib0145","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI12156","article-title":"LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation","volume":"107","author":"Cooke","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijom.2020.10.004_bib0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0602-575","article-title":"Acute graft-versus-host disease does not require alloantigen expression on host epithelium","volume":"8","author":"Teshima","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ijom.2020.10.004_bib0155","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.ijom.2020.10.004_bib0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0030-4220(82)90483-2","article-title":"The oral flora as source of septicemia in patients with acute leukemia","volume":"53","author":"Greenberg","year":"1982","journal-title":"Oral Surg"},{"key":"10.1016\/j.ijom.2020.10.004_bib0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02983793","article-title":"The pathophysiology of acute graft-versus-host disease","volume":"78","author":"Ferrara","year":"2003","journal-title":"Int J Hematol"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502720303829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502720303829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:34:34Z","timestamp":1760272474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502720303829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0901502720303829"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2020.10.004","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Association of Oral and Maxillofacial Surgeons.","name":"copyright","label":"Copyright"}]}}